These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38724608)

  • 1. Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers.
    Sakr RM; Abdelaziz AES; Mazyed EA; El Maghraby GM
    Sci Rep; 2024 May; 14(1):10680. PubMed ID: 38724608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined eutexia and amorphization for simultaneous enhancement of dissolution rate of triamterene and hydrochlorothiazide: preparation of orodispersible tablets.
    Awad HA; Fetouh MI; Sultan AA; El Maghraby GM
    Drug Dev Ind Pharm; 2024 Apr; 50(4):306-319. PubMed ID: 38400841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
    Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
    [No Abstract]   [Full Text] [Related]  

  • 5. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution enhancement of tadalafil by liquisolid technique.
    Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
    Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mohamed MS; Abdelhafez WA; Zayed G; Samy AM
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1973-1981. PubMed ID: 31692385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of novel antihypertensive orodispersible tablets.
    Khan HU; Hanif M; Sarfraz RM; Maheen S; Afzal S; Sher M; Afzal K; Mahmood A; Shamim A
    Pak J Pharm Sci; 2017 Sep; 30(5):1557-1565. PubMed ID: 29084673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Pediatric Orodispersible Tablets Based on Efavirenz as a New Therapeutic Alternative.
    de Freitas Neto JL; do Nascimento Gomes Barbosa I; de Melo CG; Ângelos MA; Dos Santos Mendes LM; Ferreira MRA; Rolim LA; Soares LAL; da Silva RMF; Neto PJR
    Curr HIV Res; 2020; 18(5):342-353. PubMed ID: 32614748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
    Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
    Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of tableting properties and dissolution rate of naproxen co-grinded with nicotinamide: preparation and characterization of co-grinded mixture.
    Khizar N; Abbas N; Ahmed M; Ahmad M; Mustafa Z; Jehangir M; Mohammed Al-Ahmary K; Hussain A; Bukhari NI; Ali I
    Drug Dev Ind Pharm; 2024 Jun; 50(6):537-549. PubMed ID: 38771120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug.
    Gupta V; Gupta M; Madan AK
    PDA J Pharm Sci Technol; 2009; 63(1):58-70. PubMed ID: 19455942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix.
    Choonara BF; Choonara YE; Kumar P; du Toit LC; Tomar LK; Tyagi C; Pillay V
    AAPS PharmSciTech; 2015 Aug; 16(4):771-86. PubMed ID: 25549792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1225-33. PubMed ID: 26555927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry.
    Khaled SA; Alexander MR; Irvine DJ; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
    AAPS PharmSciTech; 2018 Nov; 19(8):3403-3413. PubMed ID: 30097806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
    Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA
    Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative approaches in formulating floating hollow tablets
    Saab M; Issa M; Samy W; El-Maradny H
    Pharmazie; 2016 Dec; 71(12):701-708. PubMed ID: 29441998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.